These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11464050)

  • 1. The early detection and diagnosis of bladder cancer: a critical review of the options.
    Saad A; Hanbury DC; McNicholas TA; Boustead GB; Woodman AC
    Eur Urol; 2001 Jun; 39(6):619-33. PubMed ID: 11464050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of bladder cancer at 465 MHz.
    Gervino G; Autino E; Kolomoets E; Leucci G; Balma M
    Electromagn Biol Med; 2007; 26(2):119-34. PubMed ID: 17613039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bladder cancer biomarkers].
    Dobrowolska-Glazar B; Glazar W; Dobrowolski Z; Lipczyński W
    Przegl Lek; 2010; 67(7):479-83. PubMed ID: 21387760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current bladder tumor tests: does their projected utility fulfill clinical necessity?
    Lokeshwar VB; Soloway MS
    J Urol; 2001 Apr; 165(4):1067-77. PubMed ID: 11257640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer. II. Molecular aspects and diagnosis.
    Kausch I; Böhle A
    Eur Urol; 2001 May; 39(5):498-506. PubMed ID: 11464029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic biomarkers in non-muscle invasive bladder cancer.
    Faiena I; Rosser CJ; Chamie K; Furuya H
    World J Urol; 2019 Oct; 37(10):2009-2016. PubMed ID: 30467596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
    Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
    Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in biomarker technology for bladder cancers.
    Burchardt M; Burchardt T; Shabsigh A; De La Taille A; Benson MC; Sawczuk I
    Clin Chem; 2000 May; 46(5):595-605. PubMed ID: 10794739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
    Kausch I; Böhle A
    Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer.
    Lahme S; Bichler KH; Feil G; Krause S
    Urol Int; 2001; 66(2):72-7. PubMed ID: 11223747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NMP22 Bladder Check Test in early detection of bladder cancer with recurrence.
    Kundal VK; Pandith AA; Hamid A; Shah A; Kundal R; Wani SM
    Asian Pac J Cancer Prev; 2010; 11(5):1279-82. PubMed ID: 21198277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
    Mbeutcha A; Lucca I; Mathieu R; Lotan Y; Shariat SF
    Urol Clin North Am; 2016 Feb; 43(1):47-62. PubMed ID: 26614028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urine-based diagnostics: an update on the Kiel Tumor Bank].
    Hautmann S; Lokeshwar VB; Juenemann KP
    Urologe A; 2009 Jun; 48(6):619-24. PubMed ID: 19557467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of bladder cancer in voided urine samples].
    Thomas A; Renard I; Waltregny D
    Rev Med Liege; 2009; 64 Spec No():9-14. PubMed ID: 20085009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.
    Grossman HB; Soloway M; Messing E; Katz G; Stein B; Kassabian V; Shen Y
    JAMA; 2006 Jan; 295(3):299-305. PubMed ID: 16418465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of urinary biomarkers in early bladder cancer diagnosis.
    Lam T; Nabi G
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research progress in potential urinary markers for the early detection, diagnosis and follow-up of human bladder cancer.
    Wang HF; Wang JS
    Asian Pac J Cancer Prev; 2012; 13(5):1723-6. PubMed ID: 22901111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer.
    Eissa S; Shabayek MI; Ismail MF; El-Allawy RM; Hamdy MA
    IUBMB Life; 2010 May; 62(5):394-9. PubMed ID: 20408180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.